These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8664733)

  • 1. Neuroleptic prescribing in residents of nursing homes. Use may be justified if other factors have been considered.
    Tobiansky R; Blanchard M
    BMJ; 1996 Jun; 312(7047):1668-9. PubMed ID: 8664733
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroleptic prescribing in residents of nursing homes. Dangerous to extrapolate local audit findings.
    McAllister-Williams RH; Ferrier IN
    BMJ; 1996 Jun; 312(7047):1667; author reply 1669. PubMed ID: 8664729
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroleptic prescribing in residents of nursing homes. Access to psychiatrists should be improved.
    Tarbuck AF
    BMJ; 1996 Jun; 312(7047):1667-8; author reply 1669. PubMed ID: 8664730
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroleptic prescribing in residents of nursing homes. Substantial study is imminent.
    Thacker S; Jones R
    BMJ; 1996 Jun; 312(7047):1668; author reply 1669. PubMed ID: 8664732
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroleptic prescribing in residents of nursing homes. Behaviour problems are underdocumented.
    Cameron H; Reid W; Fisher C; Stott DJ
    BMJ; 1996 Jun; 312(7047):1668; author reply 1669. PubMed ID: 8664731
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroleptic prescribing in residents of nursing homes. Geographical differences make extrapolation difficult.
    Passmore AP; Crawford VL; Beringer TR; Fullerton KJ; McCaffrey PM
    BMJ; 1996 Jun; 312(7047):1667. PubMed ID: 8664728
    [No Abstract]   [Full Text] [Related]  

  • 7. Nursing homes underreport antipsychotic prescribing.
    Briesacher BA; Mui B; Devlin JW; Koethe B
    Aging Ment Health; 2020 Apr; 24(4):668-672. PubMed ID: 30724582
    [No Abstract]   [Full Text] [Related]  

  • 8. Dementia care in nursing homes: a golden opportunity.
    Bonner A
    Int Psychogeriatr; 2014 Mar; 26(3):361-2. PubMed ID: 24476937
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of neuroleptic drug use by nursing home elderly under proposed Medicare and Medicaid regulations.
    Garrard J; Makris L; Dunham T; Heston LL; Cooper S; Ratner ER; Zelterman D; Kane RL
    JAMA; 1991 Jan 23-30; 265(4):463-7. PubMed ID: 1670645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of second-generation antipsychotics on the use of antiparkinson agents in nursing homes and assisted-living facilities.
    Touré JT; Brandt NJ; Limcangco MR; Briesacher BA
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):25-35. PubMed ID: 16730618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic drug use among nursing home residents taking rivastigmine.
    Iraqi A; Hughes TL
    J Am Med Dir Assoc; 2006 Jun; 7(5):337-8. PubMed ID: 16765876
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of person-centred care on antipsychotic drug use in nursing homes (EPCentCare): study protocol for a cluster-randomised controlled trial.
    Richter C; Berg A; Fleischer S; Köpke S; Balzer K; Fick EM; Sönnichsen A; Löscher S; Vollmar HC; Haastert B; Icks A; Dintsios CM; Mann E; Wolf U; Meyer G
    Implement Sci; 2015 Jun; 10():82. PubMed ID: 26037324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability between nursing homes in prevalence of antipsychotic use in patients with dementia.
    Kleijer BC; van Marum RJ; Frijters DH; Jansen PA; Ribbe MW; Egberts AC; Heerdink ER
    Int Psychogeriatr; 2014 Mar; 26(3):363-71. PubMed ID: 24252349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic Drug Prescribing in Nursing Homes.
    Westbury JL
    JAMA; 2017 Nov; 318(18):1829-1830. PubMed ID: 29136436
    [No Abstract]   [Full Text] [Related]  

  • 15. Antipsychotic Drug Prescribing in Nursing Homes.
    Gillick MR
    JAMA; 2017 Nov; 318(18):1829. PubMed ID: 29136435
    [No Abstract]   [Full Text] [Related]  

  • 16. Antipsychotic Drug Prescribing In Nursing Homes-Reply.
    Gurwitz JH; Bonner A; Berwick DM
    JAMA; 2017 Nov; 318(18):1830. PubMed ID: 29136441
    [No Abstract]   [Full Text] [Related]  

  • 17. The quality of antipsychotic drug prescribing in nursing homes.
    Briesacher BA; Limcangco MR; Simoni-Wastila L; Doshi JA; Levens SR; Shea DG; Stuart B
    Arch Intern Med; 2005 Jun; 165(11):1280-5. PubMed ID: 15956008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why and how antipsychotic drugs are used in 40 Sydney nursing homes.
    Snowdon J; Day S; Baker W
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1146-52. PubMed ID: 16315158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving Nursing Home Compliance via Revised Antipsychotic Use Survey Tool.
    Bach LL; Lazzaretto DL; Young CF; Lofholm PW
    Consult Pharm; 2017 Apr; 32(4):228-238. PubMed ID: 28376988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organizational Factors Associated With Inappropriate Neuroleptic Drug Prescribing in Nursing Homes: A Multilevel Approach.
    Laffon de Mazières C; Lapeyre-Mestre M; Vellas B; de Souto Barreto P; Rolland Y
    J Am Med Dir Assoc; 2015 Jul; 16(7):590-7. PubMed ID: 25769961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.